search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Regulations


UK MDR or not UK MDR? The question for SSDs


What do sterile services departments need to know about the UK Medical Devices Regulations? Jack Walters provides an insight into the ‘UK MDR for Healthcare Organisations’ and discusses how this applies to the reprocessing of surgical instruments.


Statutory Instrument 2002 No. 618 “The Medical Devices Regulations 2002” has something of a murky applicability to Sterile Service Departments (SSDs). Clearly reprocessable medical devices purchased by healthcare organisations need to be compliant with these regulations. However, what about the surgical instrument sets that are put together? Is the SSD “manufacturing” a procedure pack? If so, how and when are they “placed on the market”? In addition, how does this relate to what kind of controls, including third party certification and registration, the SSD needs?


The myth You would be forgiven for thinking that healthcare organisations offering the decontamination of reusable medical devices to another legal entity are subject to the requirements of the UK MDR. Perhaps this is something you were told at some point by your auditor or perhaps you read it in your


“Health Technical Memorandum”.1,2 However,


did you know this is in direct contradiction with guidance published by the Medicines and Healthcare products Regulatory Agency (MHRA)?


The MHRA states that: “Sterilisation of devices such as surgical instruments is…not covered by the regulations as long as there is no change of ownership or new procedure pack needed”.3 This suggests that transfer of instruments


from one legal entity to another solely for the purposes of reprocessing does not automatically mean that UK MDR applies. One of two additional criteria must be met – the creation of a new procedure pack or change of ownership.


Who is right? Let us leave aside the fact that HTM 01-01, WHTM 01-01 and SHTM 01-01 are overdue for an update in a post-Brexit regulatory framework anyway; they appear to have over-simplified things


incorrectly in the first place. What is important, however, is that it is not the Department of Health, or their equivalents in Wales & Scotland, that are responsible for enforcement of UK MDR, but the MHRA.4


What do the regulations themselves say? There are a few key concepts that need to be explained here: “Placing on the market” means, in relation to a medical device, the first making available in return for payment or free of charge of a new or fully refurbished device, other than a device intended for clinical investigation, with a view to distribution, use, or both, on the GB market.5 This is a bit of a mouthful, but the key


takeaway here is “first making available”, i.e., a medical device can only be placed on the market once. This is why the MHRA makes a distinction of the creation of a new procedure pack. Once a new procedure pack has been placed on the market, it can’t be placed on the market again, no matter how many times it is exchanged between one organisation and another after this first ‘making available’. So, where are the MHRA getting this concept


of “transfer of ownership”? It is not explicit in the definition of “placing on the market” outlined above, as “making available” isn’t further defined in the UK MDR. For such a clarification, the most pertinent source appears to be from the Department of Business and Trade which states on the GOV.UK website that: A product is placed on the market when it is first made available for distribution, consumption or use on the GB market as part of a commercial activity. This can be in return for payment or free of charge. This happens after a product has been fully manufactured. A product is placed on the market when an offer or agreement is made for the transfer of ownership, possession or any other property right. Placing on the market can take place before the physical transfer of


May 2024 I www.clinicalservicesjournal.com 39





Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68